Fresenius Medical Care AG (FME), the world's leading provider of products and services for people with kidney diseases, will present new research showing how hemodiafiltration (HDF) is associated with ...

Mallinckrodt plc, a global specialty pharmaceutical company, today announced the presentation of two posters on terlipressin in patients with hepatorenal syndrome-acute kidney injury (HRS-AKI), at ...

MediBeacon Inc., a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, today announced that data from the Company’s transdermal GFR ...

Generated $459 million in 3Q 2025 revenues, including $178 million in U.S. net product salesReceived 152 new patient start forms for EMPAVELI® ...

Foamy urine can be a sign of kidney trouble, but it is not always serious. Research shows only a third of people with foamy ...

Spring Clinical Meetings registration is now open! SCM26 will take place at the New Orleans Ernest N. Morial Convention Center in New Orleans, LA. Pre-conference courses start on May 6, with the ...

In his opening statement, Nelson Mullins’ Michael A. Brown, representing the company, said evidence would show the talc did ...

The new unit marks a milestone in advancing first in-human, early phase trials, supporting cancer therapies and preparing for ...

Vertex Pharmaceuticals’ povetacicept – This BAFF/APRIL dual-pathway inhibitor has emerged as a strong contender in the MN pipeline. Nephrologists view the differentiated mechanism as addressing core ...

The current recommended urine protein to creatinine ratio is arbitrary, and a lower bar would capture more lupus nephritis ...